Stockhead on MSN12m
Health Check: Opthea’s solvency in question after monumental phase III eye disease trial failure
One of two of Opthea's phase III trials for a common eye disease has failed to meet its objectives, casting doubts on the ...
Green Queen47m
What Does Cultivated Meat Actually Taste Like? We Asked People Who’ve Tried the Real Thing
With a number of startups hosting public tastings of cultivated meat, three taste-testers take us behind the scenes of what ...
TAG24 on MSN5m
Would you let a robot draw your blood? Health systems in US think so
Several health systems across the US are gearing up to try a new way of drawing blood: using a robot.Health systems have agreed to be part of a clinical trial of a device that automates blood ...
The Manila Times12m
ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China
Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced the successful completion of the Phase III clinical study ...
HotCopper on MSN42m
'Maximising the potential': Neurizon prepares for HEALEY study of ALS
Neurizon Therapeutics (ASX:NUZ) has shared an update on its preparations for its HEALEY ALS Platform Trial – a multicentre, ...